Improving Method Transfer Outcomes
Posted: 14 March 2025 | | No comments yet
ACD/Labs and the Separation SME team at Pfizer collaborated to create a feature within Method Selection Suite to vary method parameters. With this tool methods are automatically generated for all possible combinations of parameter variations—enabling seamless method transfer without impacting method performance.
Related content from this organisation
Related topics
Biopharmaceuticals, Chromatography, Drug Development, Formulation, Research & Development (R&D), Therapeutics